Table: Sapporo Clinical Lab -2024/25 group forecast
May 7 (Reuters) -
Sapporo Clinical Laboratory Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2025 Mar 31, 2025
LATEST PREVIOUS
FORECAST FORECAST
Sales 20.13 19.80
Operating 706 mln 500 mln
Recurring 707 mln 493 mln
Net 464 mln 320 mln
EPS 148.35 yen 102.36 yen
NOTE - Sapporo Clinical Laboratory Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T
Recent news on Sapporo Clinical Laboratory
See all newsTable: Sapporo Clinical Lab - 9-MTH group results
Table: Sapporo Clinical Lab - 6-MTH group results
Brief: Sapporo Clinical Laboratory Inc - To Retire Treasury Shares Worth 26% Of Outstanding Stock On Feb 17
Table: Sapporo Clinical Lab -Q1 group results
Table: Sapporo Clinical Lab -2024/25 parent results